{"id":8407,"date":"2021-12-16T13:28:02","date_gmt":"2021-12-16T18:28:02","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/lisiraglide-cas-320367-13-3-la-chat-chu-van-thu-the-giong-nhu-glucagon-peptide-1-glp-1\/"},"modified":"2021-12-16T13:28:02","modified_gmt":"2021-12-16T18:28:02","slug":"lisiraglide-cas-320367-13-3-la-chat-chu-van-thu-the-giong-nhu-glucagon-peptide-1-glp-1","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/vi\/product\/lisiraglide-cas-320367-13-3-la-chat-chu-van-thu-the-giong-nhu-glucagon-peptide-1-glp-1\/","title":{"rendered":"Lisiraglide CAS 320367-13-3 l\u00e0 ch\u1ea5t ch\u1ee7 v\u1eadn th\u1ee5 th\u1ec3 gi\u1ed1ng nh\u01b0 glucagon peptide-1 (GLP-1)"},"content":{"rendered":"<h2><strong>Lisiraglide CAS 320367-13-3 l\u00e0 ch\u1ea5t ch\u1ee7 v\u1eadn th\u1ee5 th\u1ec3 gi\u1ed1ng nh\u01b0 glucagon peptide-1 (GLP-1)<\/strong><\/h2>\n<p> T\u00ean s\u1ea3n ph\u1ea9m: Lixisenatide<br \/>\n T\u1eeb \u0111\u1ed3ng ngh\u0129a: Lixisenatide,&gt; 98%; lixisenatide; Lixisenatide | Lixisenatide Acetate; Lixisenatide Acetate; Lixisenatide USP \/ EP \/ BP<br \/>\n CAS: 320367-13-3<br \/>\n MF: C215H347N61<br \/>\n MW: 4858.53<br \/>\n EINECS:<br \/>\n Danh m\u1ee5c s\u1ea3n ph\u1ea9m:<br \/>\n Mol T\u1ec7p: 320367-13-3.mol <\/p>\n<p> Lisiraglide l\u00e0 m\u1ed9t peptide gi\u1ed1ng glucagon-1 (GLP-1) ch\u1ea5t ch\u1ee7 v\u1eadn th\u1ee5 th\u1ec3, m\u1ed9t lo\u1ea1i hormone gi\u00fap b\u00ecnh th\u01b0\u1eddng h\u00f3a l\u01b0\u1ee3ng \u0111\u01b0\u1eddng trong m\u00e1u. T\u00ednh an to\u00e0n v\u00e0 hi\u1ec7u qu\u1ea3 c\u1ee7a thu\u1ed1c \u0111\u00e3 \u0111\u01b0\u1ee3c \u0111\u00e1nh gi\u00e1 trong 10 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u1edbi t\u1ed5ng s\u1ed1 5.400 b\u1ec7nh nh\u00e2n m\u1eafc b\u1ec7nh ti\u1ec3u \u0111\u01b0\u1eddng lo\u1ea1i 2. Trong nh\u1eefng th\u1eed nghi\u1ec7m n\u00e0y, lisiramide \u0111\u01b0\u1ee3c \u0111\u00e1nh gi\u00e1 l\u00e0 \u0111\u01a1n tr\u1ecb li\u1ec7u v\u00e0 k\u1ebft h\u1ee3p v\u1edbi c\u00e1c thu\u1ed1c \u0111i\u1ec1u tr\u1ecb ti\u1ec3u \u0111\u01b0\u1eddng kh\u00e1c \u0111\u01b0\u1ee3c FDA ch\u1ea5p thu\u1eadn, bao g\u1ed3m metformin, sulfonylureas, pioglitazone v\u00e0 insulin n\u1ec1n. Trong nh\u1eefng th\u1eed nghi\u1ec7m n\u00e0y, vi\u1ec7c s\u1eed d\u1ee5ng lisiramide \u0111\u00e3 c\u1ea3i thi\u1ec7n m\u1ee9c hemoglobin glycated (m\u1ed9t ch\u1ec9 b\u00e1o v\u1ec1 m\u1ee9c \u0111\u01b0\u1eddng huy\u1ebft). Ngo\u00e0i ra, h\u01a1n 6.000 b\u1ec7nh nh\u00e2n ti\u1ec3u \u0111\u01b0\u1eddng lo\u1ea1i 2 c\u00f3 nguy c\u01a1 m\u1eafc b\u1ec7nh tim m\u1ea1ch do x\u01a1 v\u1eefa \u0111\u1ed9ng m\u1ea1ch \u0111\u00e3 \u0111\u01b0\u1ee3c \u0111i\u1ec1u tr\u1ecb b\u1eb1ng lisiramide ho\u1eb7c gi\u1ea3 d\u01b0\u1ee3c trong Th\u1eed nghi\u1ec7m k\u1ebft qu\u1ea3 tim m\u1ea1ch. Vi\u1ec7c s\u1eed d\u1ee5ng lisiramide \u1edf nh\u1eefng b\u1ec7nh nh\u00e2n n\u00e0y kh\u00f4ng l\u00e0m t\u0103ng nguy c\u01a1 bi\u1ebfn c\u1ed1 tim m\u1ea1ch c\u00f3 h\u1ea1i. Lisiragide kh\u00f4ng n\u00ean \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb b\u1ec7nh nh\u00e2n ti\u1ec3u \u0111\u01b0\u1eddng lo\u1ea1i 1 ho\u1eb7c b\u1ec7nh nh\u00e2n b\u1ecb t\u0103ng ceton ho\u1eb7c n\u01b0\u1edbc ti\u1ec3u trong m\u00e1u (nhi\u1ec5m toan ceton do ti\u1ec3u \u0111\u01b0\u1eddng). C\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 th\u01b0\u1eddng g\u1eb7p nh\u1ea5t li\u00ean quan \u0111\u1ebfn lisiramide l\u00e0 bu\u1ed3n n\u00f4n, n\u00f4n, nh\u1ee9c \u0111\u1ea7u, ti\u00eau ch\u1ea3y v\u00e0 ch\u00f3ng m\u1eb7t. H\u1ea1 \u0111\u01b0\u1eddng huy\u1ebft l\u00e0 m\u1ed9t t\u00e1c d\u1ee5ng ph\u1ee5 th\u01b0\u1eddng g\u1eb7p kh\u00e1c \u1edf nh\u1eefng b\u1ec7nh nh\u00e2n \u0111\u01b0\u1ee3c \u0111i\u1ec1u tr\u1ecb b\u1eb1ng lisiramide v\u00e0 c\u00e1c lo\u1ea1i thu\u1ed1c tr\u1ecb \u0111\u00e1i th\u00e1o \u0111\u01b0\u1eddng kh\u00e1c nh\u01b0 sulfonylureas v\u00e0 \/ ho\u1eb7c c\u00e2y tr\u1ed3ng n\u1ec1n. Ngo\u00e0i ra, c\u00e1c ph\u1ea3n \u1ee9ng qu\u00e1 m\u1eabn nghi\u00eam tr\u1ecdng (bao g\u1ed3m qu\u00e1 m\u1eabn) \u0111\u00e3 \u0111\u01b0\u1ee3c b\u00e1o c\u00e1o trong c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u1edbi Lisiragib. <\/p>\n<p> Lixisenatide l\u00e0 m\u1ed9t lo\u1ea1i thu\u1ed1c hi\u1ec7n \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb b\u1ec7nh ti\u1ec3u \u0111\u01b0\u1eddng v\u00e0 c\u0169ng l\u00e0 m\u1ed9t ch\u1ea5t ch\u1ee7 v\u1eadn th\u1ee5 th\u1ec3 GLP-1. Lixisenatide (Lyxumia) \u0111\u00e3 \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t \u0111\u1ec3 ti\u1ebfp th\u1ecb \u1edf ch\u00e2u \u00c2u v\u00e0o n\u0103m 2013 v\u00e0 l\u00e0 ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb b\u1ec7nh ti\u1ec3u \u0111\u01b0\u1eddng d\u1ea1ng ti\u00eam d\u1ef1a tr\u00ean Lixisenatide, \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng m\u1ed7i ng\u00e0y m\u1ed9t l\u1ea7n, c\u00f9ng v\u1edbi c\u00e1c lo\u1ea1i thu\u1ed1c ho\u1eb7c insulin kh\u00e1c, cho nh\u1eefng b\u1ec7nh nh\u00e2n m\u00e0 m\u1ee9c \u0111\u01b0\u1eddng huy\u1ebft ch\u1ec9 c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c ki\u1ec3m so\u00e1t b\u1eb1ng thu\u1ed1c. &lt; &amp;&gt;<br \/>\n <strong>L\u01b0u \u00fd c\u1ee7a Lisiraglide CAS 320367-13-3<\/strong><br \/>\n Ch\u1ec9 s\u1eed d\u1ee5ng cho nghi\u00ean c\u1ee9u, kh\u00f4ng s\u1eed d\u1ee5ng cho ng\u01b0\u1eddi<\/p>\n","protected":false},"excerpt":{"rendered":"<p>T\u00ean s\u1ea3n ph\u1ea9m: Lixisenatide<br \/>\n Acetate; Lixisenatide USP \/ EP \/ BP<br \/>\n CAS: 320367-13-3<br \/>\n MF: C215H347N61O65S<br \/>\n MW: 4858.53<br \/>\n Mol T\u1ec7p: 320367-13-3.mol<\/p>\n","protected":false},"featured_media":2115,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[352],"product_tag":[1279],"class_list":{"0":"post-8407","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptide-tieu-duong","7":"product_tag-lisiraglide-cas-320367-13-3-is-a-glucagon-like-peptide-1-glp-1-receptor-agonist-vi","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/vi\/wp-json\/wp\/v2\/product\/8407","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/vi\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/vi\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/vi\/wp-json\/wp\/v2\/comments?post=8407"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/vi\/wp-json\/wp\/v2\/media\/2115"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/vi\/wp-json\/wp\/v2\/media?parent=8407"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/vi\/wp-json\/wp\/v2\/product_brand?post=8407"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/vi\/wp-json\/wp\/v2\/product_cat?post=8407"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/vi\/wp-json\/wp\/v2\/product_tag?post=8407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}